HUTCHMED (00013) Announces Retirement of Independent Non-Executive Director and Board Committee Changes

Bulletin Express03-06

HUTCHMED (00013) has announced the intended retirement of Independent Non-Executive Director, Professor Mok Shu Kam, Tony, after the conclusion of the Company’s Annual General Meeting (AGM) on May 12, 2026. Professor Mok, who has served on the Board for more than eight years, will step down to address the nine-year cap on tenure for independent non-executive directors under Hong Kong Listing Rules. Upon his retirement, he will also relinquish his roles as chairman and member of the Board committees.

The announcement details further changes effective from the end of the AGM, subject to the respective Directors’ re-election by shareholders. Dr. Renu Bhatia will be appointed as Senior and Lead Independent Non-Executive Director and will chair the Nomination Committee. Dr. Chaohong Hu will serve as the new chairman of the Technical Committee, and Professor Tan Shao Weng, Daniel will become a member of the Sustainability Committee. The Chairman of HUTCHMED, Dr. Dan Eldar, expressed appreciation for Professor Mok’s contributions and leadership in guiding the Company’s scientific and clinical development programs, highlighting his internationally recognized expertise in oncology.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1180358621?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-06 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1180358621","market":"us","top_or_hot":-1,"title":"HUTCHMED (00013) Announces Retirement of Independent Non-Executive Director and Board Committee Changes","media":"Bulletin Express","content":"<p>HUTCHMED (00013) has announced the intended retirement of Independent Non-Executive Director, Professor Mok Shu Kam, Tony, after the conclusion of the Company’s Annual General Meeting (AGM) on May 12, 2026. Professor Mok, who has served on the Board for more than eight years, will step down to address the nine-year cap on tenure for independent non-executive directors under Hong Kong Listing Rules. Upon his retirement, he will also relinquish his roles as chairman and member of the Board committees.</p>\n<p>The announcement details further changes effective from the end of the AGM, subject to the respective Directors’ re-election by shareholders. Dr. Renu Bhatia will be appointed as Senior and Lead Independent Non-Executive Director and will chair the Nomination Committee. Dr. Chaohong Hu will serve as the new chairman of the Technical Committee, and Professor Tan Shao Weng, Daniel will become a member of the Sustainability Committee. The Chairman of HUTCHMED, Dr. Dan Eldar, expressed appreciation for Professor Mok’s contributions and leadership in guiding the Company’s scientific and clinical development programs, highlighting his internationally recognized expertise in oncology.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>HUTCHMED (00013) Announces Retirement of Independent Non-Executive Director and Board Committee Changes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHUTCHMED (00013) Announces Retirement of Independent Non-Executive Director and Board Committee Changes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-06 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>HUTCHMED (00013) has announced the intended retirement of Independent Non-Executive Director, Professor Mok Shu Kam, Tony, after the conclusion of the Company’s Annual General Meeting (AGM) on May 12, 2026. Professor Mok, who has served on the Board for more than eight years, will step down to address the nine-year cap on tenure for independent non-executive directors under Hong Kong Listing Rules. Upon his retirement, he will also relinquish his roles as chairman and member of the Board committees.</p>\n<p>The announcement details further changes effective from the end of the AGM, subject to the respective Directors’ re-election by shareholders. Dr. Renu Bhatia will be appointed as Senior and Lead Independent Non-Executive Director and will chair the Nomination Committee. Dr. Chaohong Hu will serve as the new chairman of the Technical Committee, and Professor Tan Shao Weng, Daniel will become a member of the Sustainability Committee. The Chairman of HUTCHMED, Dr. Dan Eldar, expressed appreciation for Professor Mok’s contributions and leadership in guiding the Company’s scientific and clinical development programs, highlighting his internationally recognized expertise in oncology.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00013","symbol_name":"和黄医药","start_time":0,"source_url":"","article_id":"1180358621","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1180358621","pubTimestamp":1772786588,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"HUTCHMED (00013) has announced the intended retirement of Independent Non-Executive Director, Professor Mok Shu Kam, Tony, after the conclusion of the Company’s Annual General Meeting (AGM) on May...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00013":"和黄医药"},"translate_title":"和黄医药(00013)公布独立非执行董事退任及董事委员会变动","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":1},"content_text":"HUTCHMED (00013) has announced the intended retirement of Independent Non-Executive Director, Professor Mok Shu Kam, Tony, after the conclusion of the Company’s Annual General Meeting (AGM) on May 12, 2026. Professor Mok, who has served on the Board for more than eight years, will step down to address the nine-year cap on tenure for independent non-executive directors under Hong Kong Listing Rules. Upon his retirement, he will also relinquish his roles as chairman and member of the Board committees.\nThe announcement details further changes effective from the end of the AGM, subject to the respective Directors’ re-election by shareholders. Dr. Renu Bhatia will be appointed as Senior and Lead Independent Non-Executive Director and will chair the Nomination Committee. Dr. Chaohong Hu will serve as the new chairman of the Technical Committee, and Professor Tan Shao Weng, Daniel will become a member of the Sustainability Committee. The Chairman of HUTCHMED, Dr. Dan Eldar, expressed appreciation for Professor Mok’s contributions and leadership in guiding the Company’s scientific and clinical development programs, highlighting his internationally recognized expertise in oncology.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1180358621","isCrawlerRequest":true}